NUVAIRA
John joined Nuvaira in 2021 with extensive knowledge in the areas of regulatory and quality for both large-scale and start-up companies. John has over 20 years’ experience in the medical device industry and brings with him a successful track record in obtaining numerous FDA approvals for PMAs, IDEs, and 510(k)s, international regulatory approvals and successful QMS audits.
Prior to joining Nuvaira, John served as Sr. Director of Regulatory at Lutonix/CR Bard/Becton Dickinson with increasing responsibility throughout his 12 years. Earlier in his career, John served in regulatory roles for St. Jude Medical, Velocimed, Cardiac Science, and SurVivaLink.
John holds a B.S. in Electrical Engineering from the University of Minnesota and a M.B.A. from the Carlson School of Management at the University of Minnesota.
This person is not in any offices
NUVAIRA
Nuvaira is a privately held company headquartered in Minneapolis, MN. The company's proprietary Nuvaira Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD).